2, CORALreef HeFH (JAMA 2025) This phase 3 trial evaluated enlicitide in adults with heterozygous familial hypercholesterolemia (HeFH) receiving background lipid-lowering therapy
is a co-founder of Embark Laboratories and SOLID therapeutics
Is L-carnitine good for weight loss
Semaglutide for Weight Loss: A Quick Comparison Heres a quick rundown on semaglutide vs
Notably, the FDA approved a new indication for the use of Wegovy(R) to reduce the risk of serious cardiovascular events in patients with cardiovascular disease (CVD) & overweight or obesity in March 2024
Twenty patients had hepatic resection for metastasized colorectal carcinoma (mCRC), 10 for hepatocellular carcinoma (HCC), 12 for intrahepatic or perihilar cholangiocarcinoma carcinoma (iCCA/pCCA), 1 for neuroendocrine liver metastasis (NELM), 1 for non-neuroendocrine non-colorectal (NNECR) liver metastasis and 2 patients had benign liver lesions